Celularity warrants removed from Nasdaq listing

Celularity Inc. is having its warrant securities removed from listing and registration on the Nasdaq Stock Market LLC.

Rhea-AI Filing Summary

Celularity Inc. is having its warrant securities removed from listing and registration on the Nasdaq Stock Market LLC. Nasdaq states it has complied with its own rules to strike this class of securities from listing, and confirms the requirements of Section 12(b) of the Securities Exchange Act of 1934 and related SEC rules for filing Form 25 have been met.

Positive

• None.

Negative

• Celularity warrant delisting from Nasdaq removes this class of securities from a national exchange, reducing public market visibility and liquidity for the affected warrants.

Key Terms

Form 25, Section 12(b) of the Securities Exchange Act of 1934, 17 CFR 240.12d2-2, withdrawal of the class of securities from listing and registration

4 terms

Form 25 regulatory

"FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION"

A Form 25 is an official filing with the U.S. Securities and Exchange Commission used to remove a company's stock or other security from a national exchange list. Investors should care because delisting often means less visibility, lower trading volume and wider price swings—similar to a product moving from a major supermarket to a small local market, which can make buying, selling and valuing the security more difficult.

Section 12(b) of the Securities Exchange Act of 1934 regulatory

"REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES"

17 CFR 240.12d2-2 regulatory

"Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied"

A U.S. Securities and Exchange Commission rule that describes the conditions and procedural steps for a security to be removed from public registration or reporting under the Securities Exchange Act of 1934. For investors, it matters because it explains when a company’s shares can stop being subject to regular disclosure and exchange listing rules — similar to knowing when a publicly tracked product will be discontinued and no longer send updates, which affects transparency and liquidity.

withdrawal of the class of securities from listing and registration regulatory

"governing the voluntary withdrawal of the class of securities from listing and registration"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Celularity Inc. (CELU) report in this Form 25?

Celularity Inc. reports that its warrant securities are being removed from listing and registration on the Nasdaq Stock Market LLC under Section 12(b) of the Exchange Act.

Which Celularity Inc. (CELU) securities are affected by the Nasdaq action?

The action applies to a specific class of warrants of Celularity Inc. Nasdaq has moved to strike this class from listing and withdraw its registration on the exchange.

Who initiated the delisting of Celularity (CELU) warrants from Nasdaq?

The Nasdaq Stock Market LLC initiated the delisting process, certifying it has complied with its rules to strike the Celularity warrant class from listing and withdraw registration.

Has Celularity Inc. (CELU) complied with requirements for warrant delisting?

Yes. The document states Celularity has complied with the exchange’s rules and the requirements of 17 CFR 240.12d2-2(c) for voluntary withdrawal from listing and registration.

What legal basis is cited for removing Celularity (CELU) warrants from listing?

The removal is made under Section 12(b) of the Securities Exchange Act of 1934 and 17 CFR 240.12d2-2, which govern striking securities from listing and withdrawing registration.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/22/2026 - 04:24 PM Learn about SEC filing dates

UNITED STATES

OMB APPROVAL

OMB Number:			3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:			1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-38914

Issuer:	Celularity Inc
Exchange:	Nasdaq Stock Market LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	1325 Avenue of the Americas
	25th Floor
	New York	NEW YORK	10019
Telephone number:					(212) 616-3700

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Warrant

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2026-07-22	By	Katelin Rowe		CDO Analyst
Date		Name		Title

¹ Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.